These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
479 related items for PubMed ID: 28188337
1. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery. von Borstel D, A Taguibao R, A Strle N, E Burns J. Skeletal Radiol; 2017 Apr; 46(4):571-578. PubMed ID: 28188337 [Abstract] [Full Text] [Related]
2. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R. Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420 [Abstract] [Full Text] [Related]
3. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
4. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R. World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843 [Abstract] [Full Text] [Related]
5. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience. Agarwal MG, Gundavda MK, Gupta R, Reddy R. Clin Orthop Relat Res; 2018 Sep 04; 476(9):1773-1782. PubMed ID: 30794215 [Abstract] [Full Text] [Related]
6. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone]. Sørensen AL, Hansen RL, Jørgensen PH. Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237 [Abstract] [Full Text] [Related]
10. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]
11. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec 08; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
13. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage. Errani C, Tsukamoto S, Leone G, Righi A, Akahane M, Tanaka Y, Donati DM. J Bone Joint Surg Am; 2018 Mar 21; 100(6):496-504. PubMed ID: 29557866 [Abstract] [Full Text] [Related]
14. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study. Furuta T, Kubo T, Sakuda T, Saito T, Kurisu K, Muragaki Y, Adachi N. Acta Radiol; 2022 Feb 21; 63(2):176-181. PubMed ID: 33517664 [Abstract] [Full Text] [Related]
18. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May 21; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
20. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report. Park MJ, Ganjoo KN, Ladd AL. J Hand Surg Am; 2015 Aug 21; 40(8):1620-4. PubMed ID: 25935517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]